C. Primas, S. Riss, J. Pokryszka, A. Frick, Jurij Maurer, S. Dabsch, P. Schreiner, W. Reinisch, L. Kazemi-Shirazi, C. Dawoud, N. Pedarnig, H. Angermann, C. Dejaco, Michael Trauner, Gottfried Novacek, Thomas Waldhör
2026.6.19Crohns & Colitis 360
Abstract
The cumulative probability of patients with Crohn’s disease (CD) requiring a stoma at a tertiary center is unknown. We sought to evaluate the time to stoma formation after diagnosis as well as risk factors for stoma formation in CD patients. This is a retrospective, longitudinal cohort study on consecutive patients with CD at an Austrian tertiary referral university center. In brief, patients with CD were identified and disease-specific data were captured prior to June 2023. The probability of stoma-free survival by subgroups of various potential risk factors was assessed by means of Kaplan-Meier estimates (Log-rank test). Of 1267 CD patients, 142 (11.2%) underwent a stoma formation (80 ileostomies, 62 colostomies), of which 51 (35.9%) were permanent stomas. The probability of stoma-free survival at 10 and 20 years after diagnosis was 92% and 86%, respectively. Ileocolonic and colonic location, penetrating behavior, and perianal disease were associated with a higher risk for stoma formation (each p < 0.001). If these risk factors coincided, the probability of stoma-free survival at 10 and 20 years after diagnosis was only 76.4% and 67.2%, respectively. Patients diagnosed from 2000 onwards had a trend for a lower stoma risk than patients diagnosed earlier (p = 0.084). The coincidence of colonic or ileocolonic involvement, penetrating behaviour and perianal fistulas significantly reduced the probability of stoma-free survival to 68% 20 years after diagnosis. Identification of these risk factors for stoma formation may help identify patients at risk and thus raise awareness for this group.
Citation format
PRIMAS, C., et al. Stoma formation and associated risk factors in patients with crohn′s disease in an austrian tertiary referral hospital: A retrospective explorative study of long-term follow-up. Crohns & Colitis 360, 2026, 8(2): otag064.